Sex Differences in the Risk of Cardiovascular Diseases Associated With Diabetes

University College, London80,000 enrolled

Overview

To evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care

The management and treatment of adult diabetes is far from optimal. The most recent report from the National Diabetes Audit showed that only one in three people with diabetes are achieving recommended standards for controlling blood glucose, blood pressure and cholesterol levels; and only three in five received basic care processes to reduce their risk of diabetes-related complications such as blindness, amputation and kidney disease. Women did 15% worse than men, which may explain some of the reported higher excess risk of coronary heart disease and stroke, consequent to diabetes in women than men. More efficient and equitable care in people with diabetes could lead to substantial cost savings, and would improve the lives of women and men currently living with diabetes. The objective of this research isto evaluate the risk of cardiovascular events associated with medication use for controlling blood glucose, blood pressure and cholesterol levels in men and women with diabetes treated in primary care.

Study Type

OBSERVATIONAL

Enrollment

80,000

Conditions

Diabetes Mellitus

Interventions

No intervention is given.OTHER

This study is based on the analysis of linked electronic health records (CALIBER dataset)

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with diabetes at or before study entry, and participants who develop new-onset diabetes during follow-up. * Age ≥ 18 years * Data collected in the period 1997-2010 * Minimum time since registration of 1 year * Minimum of 1 year of up to standard data (CPRD quality standard) Exclusion Criteria: • None

Locations (1)

The George Institute for Global Health, Nuffield Department for Population Health, University of Oxford

Oxford, Oxford, United Kingdom

Outcomes

Primary Outcomes

First occurrence of cardiovascular disease

First recorded diagnosis of cardiovascular disease during follow-up: stable angina, unstable angina, myocardial infarction, unheralded coronary death, heart failure, transient ischaemic attack, ischaemic stroke, subarachnoid haemorrhage, intracerebral haemorrhage, peripheral arterial disease, abdominal aortic aneurysm, ventricular arrhythmia, cardiac arrest, or sudden cardiac death

Time frame: 10 years

Secondary Outcomes

Cardiovascular mortality

Composite endpoint of cardiovascular mortality

Time frame: 10 years

All cause mortality

Composite endpoint of all cause mortality

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.